[HTML][HTML] Management of immune-related adverse events associated with immune checkpoint inhibitor therapy: a minireview of current clinical guidelines
S Trinh, A Le, S Gowani, NM La-Beck - Asia-Pacific journal of oncology …, 2019 - Elsevier
Successful targeting and inhibition of the cytotoxic T-lymphocyte-associated antigen 4 and
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
[引用][C] Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: A Minireview of Current Clinical Guidelines
S Trinh, A Le, S Gowani, NM La-Beck - Asia-Pacific Journal of Oncology …, 2019 - cir.nii.ac.jp
Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor
Therapy: A Minireview of Current Clinical Guidelines | CiNii Research CiNii 国立情報学研究所 …
Therapy: A Minireview of Current Clinical Guidelines | CiNii Research CiNii 国立情報学研究所 …
[HTML][HTML] Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: A Minireview of Current Clinical Guidelines
S Trinh, A Le, S Gowani, NM La-Beck - Asia-Pacific Journal of Oncology …, 2019 - apjon.org
Successful targeting and inhibition of the cytotoxic T-lymphocyte-associated antigen 4 and
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: a Minireview of Current Clinical Guidelines
S Trinh, A Le, S Gowani… - Asia-Pacific journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Successful targeting and inhibition of the cytotoxic T-lymphocyte-associated antigen 4 and
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
[PDF][PDF] Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: a Minireview of Current Clinical Guidelines
S Trinh, A Le, S Gowani, NM La‑Beck - 2019 - academia.edu
Successful targeting and inhibition of the cytotoxic T‑lymphocyte‑associated antigen 4 and
programmed cell death‑1 protein/programmed cell death ligand 1 immune checkpoint …
programmed cell death‑1 protein/programmed cell death ligand 1 immune checkpoint …
Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: A Minireview of Current Clinical Guidelines
S Trinh, A Le, S Gowani, N La-Beck - Asia-Pacific Journal of Oncology …, 2019 - go.gale.com
Successful targeting and inhibition of the cytotoxic T-lymphocyte-associated antigen 4 and
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: a Minireview of Current Clinical Guidelines.
S Trinh, A Le, S Gowani, NM La-Beck - Asia-pacific Journal of …, 2019 - europepmc.org
Successful targeting and inhibition of the cytotoxic T-lymphocyte-associated antigen 4 and
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
[HTML][HTML] Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: a Minireview of Current Clinical Guidelines
S Trinh, A Le, S Gowani, NM La-Beck - Asia-Pacific Journal of …, 2019 - ncbi.nlm.nih.gov
Successful targeting and inhibition of the cytotoxic T-lymphocyte-associated antigen 4 and
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: A Minireview of Current Clinical Guidelines
S Trinh, A Le, S Gowani, NM La-Beck - Asia-Pacific Journal of Oncology …, 2019 - apjon.org
Successful targeting and inhibition of the cytotoxic T-lymphocyte-associated antigen 4 and
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: a Minireview of Current Clinical Guidelines.
S Trinh, A Le, S Gowani, NM La-Beck - Asia-pacific Journal of …, 2019 - europepmc.org
Successful targeting and inhibition of the cytotoxic T-lymphocyte-associated antigen 4 and
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …
programmed cell death-1 protein/programmed cell death ligand 1 immune checkpoint …